Clinical and pathological characteristics of BRCA1-associated ovarian cancer by mutation status
| No. of cases (%) | |||||
|---|---|---|---|---|---|
| L63X | Q934X | Others | |||
| Total | 14 | 17 | 79 | ||
| Age (yr) | |||||
| Mean ± SD | 52.2 ± 6.7 | 53.1 ± 11.5 | 51.9 ± 9.6 | ||
| Range | 39–65 | 28–72 | 37–79 | ||
| Histology | |||||
| Serous | 9 (69.2) | 11 (64.7) | 59 (85.5) | ||
| Endometrioid | 3 (23.1) | 3 (17.6) | 8 (11.6) | ||
| Mucinous | 0 | 0 | 0 | ||
| Clear cell | 0 | 0 | 0 | ||
| Others | 1 (7.7) | 3 (17.6) | 2 (2.9) | ||
| Unknown | 1 | 0 | 10 | ||
| Stage | |||||
| I + II | 6 (46.2)a | 5 (29.4) | 9 (14.1)a | ||
| III + IV | 7 (53.8)a | 12 (70.6) | 55 (85.9)a | ||
| Unknown | 1 | 0 | 15 | ||
a P = 0.016.